JP2019510081A5 - - Google Patents

Download PDF

Info

Publication number
JP2019510081A5
JP2019510081A5 JP2018566633A JP2018566633A JP2019510081A5 JP 2019510081 A5 JP2019510081 A5 JP 2019510081A5 JP 2018566633 A JP2018566633 A JP 2018566633A JP 2018566633 A JP2018566633 A JP 2018566633A JP 2019510081 A5 JP2019510081 A5 JP 2019510081A5
Authority
JP
Japan
Prior art keywords
taa
composition
patient
composition according
inos inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018566633A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019510081A (ja
JP7057976B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2016/082925 external-priority patent/WO2017153023A1/en
Publication of JP2019510081A publication Critical patent/JP2019510081A/ja
Publication of JP2019510081A5 publication Critical patent/JP2019510081A5/ja
Application granted granted Critical
Publication of JP7057976B2 publication Critical patent/JP7057976B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018566633A 2016-03-07 2016-12-30 被験体において胸部大動脈瘤(TAA)を同定するin vitro方法 Expired - Fee Related JP7057976B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16382103.6 2016-03-07
EP16382103 2016-03-07
PCT/EP2016/082925 WO2017153023A1 (en) 2016-03-07 2016-12-30 In vitro method for identifying thoracic aortic aneurysms (taa) in a subject

Publications (3)

Publication Number Publication Date
JP2019510081A JP2019510081A (ja) 2019-04-11
JP2019510081A5 true JP2019510081A5 (https=) 2020-02-13
JP7057976B2 JP7057976B2 (ja) 2022-04-21

Family

ID=55524277

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018566633A Expired - Fee Related JP7057976B2 (ja) 2016-03-07 2016-12-30 被験体において胸部大動脈瘤(TAA)を同定するin vitro方法

Country Status (8)

Country Link
US (2) US10907135B2 (https=)
EP (1) EP3427061B1 (https=)
JP (1) JP7057976B2 (https=)
AU (1) AU2016396401B2 (https=)
BR (1) BR112018068045A2 (https=)
CA (1) CA3017042C (https=)
ES (1) ES2965961T3 (https=)
WO (1) WO2017153023A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2555790B1 (es) 2014-06-05 2016-10-13 Consejo Superior De Investigaciones Científicas (Csic) Método de obtención de un array de micropartículas planares con multiplexado molecular superficial, array obtenido y su uso
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
EP3384043B1 (en) 2015-12-01 2020-02-19 Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) Method for diagnosing cardiomyopathies
WO2019101993A1 (en) 2017-11-24 2019-05-31 Consejo Superior De Investigaciones Científicas (Csic) A modified brucella vaccine strain for the treatment of brucellosis
EP3740592A4 (en) * 2018-02-19 2021-10-06 The General Hospital Corporation METHODS AND COMPOSITIONS FOR THE TREATMENT OF VASCULAR DISEASE
US12313635B2 (en) 2018-07-27 2025-05-27 The Regents Of The University Of California Biomarker for thoracic aortic aneurysm
EP4088118A1 (en) * 2020-01-10 2022-11-16 Deutsches Herzzentrum München des Freistaates Bayern Klinik an der Technischen Universität München Diagnosis of an aortic dissection by detecting a specific biomarker in a blood sample
US20210318336A1 (en) * 2020-04-09 2021-10-14 The Trustees Of The University Of Pennsylvania Methods for treating aortic aneurysm disease
WO2022219196A1 (en) * 2021-04-16 2022-10-20 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (F.S.P.) Method for the diagnosis, prognosis and/or treatment of thoracic aortic aneurysm

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109522A1 (en) * 2001-09-24 2003-06-12 Manning Pamela T. Ophthalmologic treatment methods using selective iNOS inhibitors
WO2014004889A2 (en) * 2012-06-27 2014-01-03 Musc Foundation For Research Development Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
ES2555790B1 (es) 2014-06-05 2016-10-13 Consejo Superior De Investigaciones Científicas (Csic) Método de obtención de un array de micropartículas planares con multiplexado molecular superficial, array obtenido y su uso
ES2612340B1 (es) 2015-10-27 2018-03-09 Consejo Superior De Investigaciones Científicas (Csic) Sensor, aparato y procedimiento para la determinación de la concentración de solutos en disoluciones
EP3384043B1 (en) 2015-12-01 2020-02-19 Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.) Method for diagnosing cardiomyopathies
CN109843312A (zh) 2016-04-29 2019-06-04 马德里自治大学 用作癌症或免疫失调患者的免疫治疗增效剂或佐剂的包含携带生物活性化合物的脂质体系的制剂
WO2017198717A1 (en) 2016-05-18 2017-11-23 Consejo Superior De Investigaciones Científicas Fusion proteins comprising an aldolase enzyme joined to a maltose binding protein
EP3681515A1 (en) 2017-09-15 2020-07-22 Fundación para la Investigación Biomédica del Hospital Universitario de la Paz (FIBHULP) Mafg as a potential therapeutic target to restore chemosensitivity in platinum-resistant cancer cells
EP3703756B1 (en) 2017-11-02 2022-04-20 Consejo Superior de Investigaciones Científicas (CSIC) Use of statins in overcoming resistance to beta-lactam antibiotics in bacterial species synthetizing isoprenoids using the mevalonate synthetic pathway
WO2019101993A1 (en) 2017-11-24 2019-05-31 Consejo Superior De Investigaciones Científicas (Csic) A modified brucella vaccine strain for the treatment of brucellosis
US20210186989A1 (en) 2018-06-06 2021-06-24 Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Enhanced trained immunity in myeloid cells by ship-1 inhibition
JP7260341B2 (ja) 2019-03-06 2023-04-18 スタンレー電気株式会社 車両用灯具の制御装置、車両用灯具の制御方法、車両用灯具システム

Similar Documents

Publication Publication Date Title
JP2019510081A5 (https=)
CN110139865A (zh) Fgfr抑制剂
JP2019519533A5 (https=)
IL259851A (en) Compounds and methods of inhibiting antidepressant nhe mediator in the treatment of disorders associated with fluid retention or overload of salts and gastrointestinal disorders
CN112004801A (zh) 一种c-MET 抑制剂的晶型及其盐型和制备方法
CN114072404A (zh) Ret选择性抑制剂及其制备方法和用途
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
JP2016041733A5 (https=)
JP2019507781A5 (https=)
JP2011528713A5 (https=)
EP2628727A3 (en) Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
JP2004534850A5 (https=)
JP2017530163A5 (https=)
JP2014533241A5 (https=)
CN113939514A (zh) 吡咯并嘧啶类化合物及其应用
JP2015521156A5 (https=)
JP2010521516A5 (https=)
CN111918672A (zh) 人工合成的鞘氨醇衍生物类脂质单体及其递送核酸的用途
CN111566100A (zh) 嘧啶类化合物、其制备方法及其医药用途
CN109661395A (zh) Pde4抑制剂
JP2009532434A5 (https=)
JP2012523416A5 (https=)
JP2013535391A5 (https=)
CN109563051A (zh) 作为pde4抑制剂的并环类化合物
CN111836819A (zh) 一种含有芳胺基取代的吡咯并嘧啶类化合物、制备方法及其应用